Catalent, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

Rhea-AI Summary

Catalent, Inc. (NYSE: CTLT) announced that its executive leadership will present virtually at the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021, at 1:15 a.m. ET. A live webcast of the presentation will be available for viewing at investor.catalent.com and can be replayed afterwards. Catalent is a global leader in development sciences and manufacturing for medicines, boasting nearly 90 years in the industry, 17,000 employees, and $4 billion in fiscal year 2021 revenue.

SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE: CTLT), the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products, today announced that members of its executive leadership team will virtually present at the Morgan Stanley 19th Annual Global Healthcare Conference at 1:15 a.m. ET on September 9, 2021.

A live webcast of the presentation will be accessible at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.
Catalent Inc. [NYSE: CTLT], an S&P 500^® company, is the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene therapies; and consumer health products. With almost 90 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance, and ensuring reliable global clinical and commercial product supply. Catalent’s workforce exceeds 17,000 people, including more than 2,500 scientists and technicians, at more than 50 facilities on four continents, and in fiscal year 2021, it generated $4 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, please visit www.catalent.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210907005041/en/

Investor Contact:

Paul Surdez, Catalent, Inc.

(732) 537-6325

investors@catalent.com

Source: Catalent, Inc.

FAQ

What is the date and time of the Catalent presentation at the Morgan Stanley Healthcare Conference?

Catalent will present virtually at the Morgan Stanley 19th Annual Global Healthcare Conference on September 9, 2021, at 1:15 a.m. ET.

Where can I access the webcast of Catalent's presentation?

The webcast of Catalent's presentation can be accessed at investor.catalent.com.

What is the primary focus of Catalent, Inc.?

Catalent is focused on development sciences and manufacturing platforms for medicines, including biotherapeutics, cell and gene therapies, and consumer health products.

What was Catalent's revenue in the fiscal year 2021?

Catalent generated $4 billion in annual revenue in fiscal year 2021.

How many employees does Catalent have?

Catalent employs over 17,000 people worldwide.